The relationship between antidepressant and analgesic responses: Findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder

Current Medical Research and Opinion

Volumn 24, Issue 11, 2008, Pages 3105-3115

  Fishbain, David A ^a,b   Detke, Michael J ^c,d,e   Wernicke, Joachim ^c   Chappell, Amy S ^c   Kajdasz, Daniel K ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Analgesia; Antidepressant; Duloxetine hydrochloride; HAMD; Serotonin norepinephrine reuptake inhibitor; Visual analog scale

Indexed keywords

BENZODIAZEPINE; CHLORAL HYDRATE; DULOXETINE; PAROXETINE; PLACEBO; ZOLPIDEM;

ADULT; ANALGESIA; ARTICLE; BACKACHE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PAIN ASSESSMENT; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SHOULDER PAIN; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; ANALGESIA; ANALGESICS; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS, PHASE III AS TOPIC; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PAIN; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THIOPHENES; TREATMENT OUTCOME;

EID: 67649394311     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990802429627     Document Type: Article

References (55)

1. Fishbain D. Evidence-based data on pain relief with antidepressants. Ann Med 2000;32:305-316 (Pubitemid 30496575)
2. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992;49:205-219
3. Philipp M, Fichinger M. Psychotropic drugs in the management of chronic pain syndromes. Pharmacopsychiatry 1993;26:221-234 (Pubitemid 24010252)
4. McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-227 (Pubitemid 27025878)
5. Fishbain DA, Cutler RB, Rosomoff HL, et al. Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis. Psychosom Med 1998;60:503-509 (Pubitemid 28354853)
6. Mochizucki D. Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Hum Psychopharmacol Clin Exp 2004;19:15-19 (Pubitemid 39386315)
7. Bomholt SF, Mikkelson JD, Blackbur-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine, and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 2005;48:252-263 (Pubitemid 40208261)
8. Turkington RW. Depression masquerading as diabetic neuropathy. JAMA 1980;243:1147-1150 (Pubitemid 10180023)
9. Fishbain DA, Cutler R, Rosomoff HL, et al. Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med 2000;1:310-316
10. Young RJ, Clarke BF. Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs. Diabet Med 1985;2:363-366 (Pubitemid 16202653)
11. Max MB, Schafer SC, Culnane M, et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38:1427-1432 (Pubitemid 18217470)
12. Guiol C, Tran MA, Blanc M, et al. Is there any relationship between antinociception, doses and plasma levels of clomipramine during subchronic treatment in rats? Biomed Pharmacother 1984;38:59-62
13. Watson CP. Therapeutic window for amitriptyline analgesia. Can Med Assoc J 1984;130:105-106 (Pubitemid 14177685)
14. Leijon G, Boivie J. Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine. Pain 1989;36:27-36 (Pubitemid 19024963)
15. Sindrup SH Brosen K, Gram LF. Antidepressants in pain treatment: antidepressant or analgesic effect? Clin Neuropharmacol 1992;15(Suppl 1, Pt A):636-7A
16. Brenne E, van der Hagen K, Maehlum E, et al. Treatment chronic pain with amitriptyline. A double-blind dosage study with determination of serum levels. Tidsskr Nor Laegeforen 1997;117:3491-3494
17. Kvinesdal B, Molin J, Froland A, et al. Imipramine treatment of painful diabetic neuropathy. JAMA 1984;251:1727-1730 (Pubitemid 14174179)
18. Montastruc JL, Tran MA, Charlet JP, et al. Analgesic properties and plasma concentrations of clomipramine in chronic pain. Rev Neurol (Paris) 1983;139:583-587
19. Edelbroek PM, Linssen AC, Zitman FG, et al. Analgesic and antidepressive effects of low-dose amitriptyline in relation to its metabolism in patients with chronic pain. Clin Pharmacol Ther 1986;39:156-162 (Pubitemid 16119817)
20. Rascol O, Tran MA, Bonnevialle P, et al. Lack of correlation between plasma levels of amitriptyline (and nortriptyline) and clinical improvement of chronic pain of peripheral neurologic origin. Clin Neuropharmacol 1987;10:560-564 (Pubitemid 17167174)
21. Forssell H, Tasmuth T, Tenovuo O, et al. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial. J Orofac Pain 2004;18:131-137 (Pubitemid 38623995)
22. Detke MJ, Lu Y, Goldstein DJ, et al. Duloxetine, 60mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 2002;63:308-315 (Pubitemid 34456358)
23. Detke MJ, Lu Y, Goldstein DJ, et al. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res 2002;36:383-390 (Pubitemid 35254112)
24. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. J Clin Psychopharmacol 2004;24:389-399 (Pubitemid 38944137)
25. Detke MJ, Wiltse CG, Mallinckrodt CH, et al. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur Neuropsychopharmacol 2004;14:457-470 (Pubitemid 39626894)
26. Perahia DG, Wang F, Mallinckrodt CH, et al. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine- controlled trial. Eur Psychiatry 2006;21:367-378
27. Nemeroff CB, Schatzberg AF, Goldstein DS, et al. Duloxetine for the treatment of major depressive disorder. Psychopharmacol Bull 2002;36:106-132
28. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
30. Guy W, ed. ECDEU Assessment Manual for Psychopharmacology, revised 1976. Rockville, MD: National Institutes of Mental Health, 1976:217-222
31. DeLoach LJ, Higgins MS, Caplan AB, et al. The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesth Analg 1998;86:102-106 (Pubitemid 28040099)
32. Hirschfeld RM, Mallinckrodt C, Lee TC, et al. Time course of depression-symptom improvement during treatment with duloxetine. Depress Anxiety 2005;21:170-177 (Pubitemid 41170386)
33. Krell HV, Leuchter AF, Morgan M, et al. Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry 2004;65:1174-1179
34. Watson CP, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671-673
35. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-596 (Pubitemid 17057933)
36. Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990;47:305-312 (Pubitemid 20115016)
37. Farrar JT. What is clinically meaningful: outcome measures in pain clinical trials. Clin J Pain 2000;16(2 Suppl):106-112 (Pubitemid 30395253)
38. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256
39. Huuhka MJ, Haanpaa ML, Leinonen EV. Electroconvulsive therapy in patients with depression and fibromyalgia. Eur J Pain 2004;8:371-376 (Pubitemid 38859667)
40. Newman SP, Fitzpatrick R, Lamb R, et al. The origins of depressed mood in rheumatoid arthritis. J Rheumatol 1989;16:740-744 (Pubitemid 19182956)
41. Dickens C, Jayson M, Sutton C, et al. The relationship between pain and depression in a trial using paroxetine in sufferers of chronic low back pain. Psychosomatics 2000;41:490-499 (Pubitemid 30832672)
42. Melzack R, Casey KL. Sensory, motivational, and central control determinants of pain: a new conceptual model. In: Kenshalo D, ed. The Skin Senses. Springfield, IL: CC Thomas, 1968:423-443
43. Gracely RH, Petzke F, Wolf JM, et al. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46:1333-1343 (Pubitemid 34525843)
44. Gracely RH, Grant MA, Giesecke T. Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 2003;17:593-609 (Pubitemid 36869130)
45. Cook DB, Lange G, Ciccone DS, et al. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004;31:364-378 (Pubitemid 38160761)
46. Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005;52:1577-1584 (Pubitemid 40663950)
47. Posternak MA, Zimmerman M. Is there a delay in the antidepressant effect? A meta-analysis. J Clin Psychiatry 2005;66:148-158 (Pubitemid 40314320)
48. Brannan SK, Mallinckrodt CH, Detke MJ, et al. Onset of action for duloxetine 60 mg once daily: double-blind, placebocontrolled studies. J Psych Res 2004;39:161-172 (Pubitemid 39602640)
49. Taylor MJ, Freemantle N, Geddes JR, et al. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 2006;63:1217-1223 (Pubitemid 44708080)
50. Wernicke J, Lu Y, D'Souza D, et al. Antidepressants: Duloxetine at doses of 60 mgQDand 60 mg BID is effective in the treatment of diabetic neuropathic pain (DPN). J Pain 2004;5(Suppl 1):S48
51. Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 2003;60:39-47 (Pubitemid 36070863)
52. Fava M, Mallinckrodt CH, Detke MJ, et al. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 2004;65:521-530
53. Fishbain DA. Analgesic effects of antidepressants. J Clin Psychiatry 2003;64:96
54. Karp JF, Weiner D, Seligman K, et al. Body pain and treatment response in late-life depression. Am J Geriatr Psychiatry 2005;13:188-194 (Pubitemid 41031086)
55. Karp JF, Scott J, Houck P, et al. Pain predicts longer time to remission during treatment of recurrent depression. J Clin Psychiatry 2005;66:591-597 (Pubitemid 40733701)